GENE-CELL TECHNOLOGIES – A CHANCE FOR PATIENTS, A CHALLENGE FOR HEALTHCARE SYSTEMS
Sergey Kutsev, Director, Research Centre for Medical Genetics; Chief External Expert in Medical Genetics of the Ministry of Health of the Russian Federation
Igor Kagramanyan, First Deputy Minister of Health of the Russian Federation (online)
Igor Korobko, Head of Science and Innovative Development of Health Department, Ministry of Health of the Russian Federation
Ekaterina Pogodina, Director General, Johnson & Johnson Russia & CIS, Managing Director, Janssen, Pharmaceutical Division of Johnson & Johnson, Russia & CIS
Over the past decade, there has been rapid development of personalized medicine, genetic, cellular and genomic technologies in healthcare worldwide, including active practical application of drugs that directly target the cause of disease at the genetic and cellular level. With these technologies, it is possible to efficiently fight the diseases once considered incurable. But they also pose a challenge to healthcare systems, as their specificity and frequently high cost require new approaches to regulating their circulation in the market and the most important aspect – that of accessibility to patients.